SLC12A5 and central nervous system cancer: Furthermore, NMDA receptor activity is known to inhibit KCC2 expression (Lee et al., 2011), and the hyperactive glutamate receptor activity, as observed in our study, could trigger the dysregulation of chloride homeostasis in patients with glioma.